EPISODE · May 7, 2021 · 18 MIN
Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness
from HCPLive Podcasts · host HCPLive.com
Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.
NOW PLAYING
Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m